Viability and metabolic activities are important characteristics of probiotic microorganisms. They give rise to therapeutic benefits as well as increase physiological activity of cultured products through liberation of a number of bioactive peptides and activation of latent compounds such as conjugated isoflavones. The main focus of this project was to assess the performance of commercial probiotic strains in regard to viability, metabolic activity and ability to produce bioactive compounds.